FerroKin BioSciences Report issue

For profit Phase 1
Founded: San Carlos CA United States (2007)
Status: Acquired by Shire (2012) → now Takeda (2018)

Organization Overview

First Clinical Trial
2009
NCT01039636
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (1)

deferitazole (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

beta-Thalassemia (Phase 1)

Iron Overload (Phase 1)

Thalassemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1